Search results
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 4 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
Pfizer shares the ADC data that convinced it to start a Phase 3 lung cancer trial
Endpoints News· 3 days agoWhen Pfizer laid out the ambitious vision for its new oncology division in February, it announced...
Pfizer announces another $1.5B in cost cuts — and plans for more to come
Endpoints News· 4 days agoMonths after beginning a $4 billion savings strategy, Pfizer is planning on a new $1.5 billion round...
1 Top Dividend Stock to Load Up On Now
Motley Fool via Yahoo Finance· 5 days agoThey are the bedrock of a portfolio designed for the long haul, offering a balance of stability and growth potential. One healthcare giant stands out In...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 4 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
How To Know If Pfizer Inc.
Marketing Sentinel· 2 days agoIn last trading session, Pfizer Inc. (NYSE:PFE) saw 22.51 million shares changing hands with its beta currently measuring 0.68. Company’s recent per share price level of $28.88 ...
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 3 days agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...
Pfizer to Cut Costs in Multi-Year Effort — Update
Morningstar· 4 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio enhancements. The first ...
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 6 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
